EE9900524A - N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena - Google Patents

N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena

Info

Publication number
EE9900524A
EE9900524A EEP199900524A EEP9900524A EE9900524A EE 9900524 A EE9900524 A EE 9900524A EE P199900524 A EEP199900524 A EE P199900524A EE P9900524 A EEP9900524 A EE P9900524A EE 9900524 A EE9900524 A EE 9900524A
Authority
EE
Estonia
Prior art keywords
indolecarboxamides
cck
triazolyl
agonists
Prior art date
Application number
EEP199900524A
Other languages
English (en)
Inventor
Bignon Eric
Bras Jean-Pierre
De Cointet Paul
Despeyroux Pierre
Frehel Daniel
Gully Danielle
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE9900524A publication Critical patent/EE9900524A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
EEP199900524A 1997-05-13 1998-05-06 N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena EE9900524A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (fr) 1997-05-13 1997-05-13 Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1998/000905 WO1998051686A1 (fr) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides et leur utilisation comme agonistes de cck-a

Publications (1)

Publication Number Publication Date
EE9900524A true EE9900524A (et) 2000-06-15

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900524A EE9900524A (et) 1997-05-13 1998-05-06 N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena

Country Status (35)

Country Link
EP (1) EP0984960B1 (et)
JP (1) JP2001524980A (et)
KR (1) KR20010012541A (et)
CN (1) CN1263528A (et)
AR (1) AR011729A1 (et)
AT (1) ATE232207T1 (et)
AU (1) AU725530B2 (et)
BR (1) BR9811465A (et)
CA (1) CA2289573A1 (et)
CO (1) CO4940485A1 (et)
CZ (1) CZ289484B6 (et)
DE (1) DE69811223T2 (et)
DK (1) DK0984960T3 (et)
DZ (1) DZ2486A1 (et)
EE (1) EE9900524A (et)
ES (1) ES2190081T3 (et)
FR (1) FR2763337B1 (et)
GT (1) GT199800068A (et)
HR (1) HRP980258B1 (et)
HU (1) HUP0002763A3 (et)
ID (1) ID22911A (et)
IL (1) IL132903A0 (et)
IS (1) IS5235A (et)
NO (1) NO995513L (et)
NZ (1) NZ500637A (et)
PL (1) PL336772A1 (et)
RU (1) RU2175323C2 (et)
SI (1) SI0984960T1 (et)
SK (1) SK154299A3 (et)
TR (1) TR199902795T2 (et)
TW (1) TW396155B (et)
UY (1) UY24997A1 (et)
WO (1) WO1998051686A1 (et)
YU (1) YU57999A (et)
ZA (1) ZA983997B (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2815963B1 (fr) * 2000-10-26 2003-02-28 Sanofi Synthelabo Nouveaux derives du triazole et les compositions pharmaceutiques les contenant
EA200300238A1 (ru) * 2000-10-26 2003-10-30 Санофи-Синтелябо Триазольные производные и фармацевтические композиции, содержащие их
HUP0004741A2 (hu) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Kémiai eljárás tiazolszármazékok előállítására és új intermedier
MXPA04002931A (es) * 2001-10-12 2005-04-11 Bayer Pharmaceuticals Corp Heterociclos que contienen nitrogeno de 5 miembros sustituidos con fenilo para el tratamiento de la obesidad.
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
AU2008209472A1 (en) 2007-01-26 2008-07-31 Merck Sharp & Dohme Corp. Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
KR20110028661A (ko) * 2008-07-15 2011-03-21 노파르티스 아게 Dgat1 억제제로서의 헤테로아릴 유도체
KR101444559B1 (ko) * 2009-06-09 2014-09-26 액테리온 파마슈티칼 리미티드 불화 아미노트리아졸 유도체
EP2490657B1 (de) * 2009-10-22 2017-01-18 Henkel AG & Co. KGaA Mittel zur behandlung keratinhaltiger fasern, enthaltend eine nichtionische, mittels propylenoxid modifizierte stärke und ein weiteres filmbildendes und/oder festigendes nichtionisches polymer
CN106928147A (zh) * 2017-03-14 2017-07-07 华东师范大学 三环二萜类似物及其制备方法、及其在制备抗前列腺癌药物中的应用
CN107271623A (zh) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 基于人体饱腹感的啤酒可饮性评价方法
AU2020363377A1 (en) 2019-10-07 2022-04-21 Kallyope, Inc. GPR119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (fr) * 1993-02-19 1995-05-19 Sanofi Elf Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament.
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
HUP0002763A2 (hu) 2001-06-28
NO995513D0 (no) 1999-11-11
FR2763337B1 (fr) 1999-08-20
TR199902795T2 (xx) 2000-02-21
FR2763337A1 (fr) 1998-11-20
GT199800068A (es) 1999-11-11
YU57999A (sh) 2002-06-19
IL132903A0 (en) 2001-03-19
KR20010012541A (ko) 2001-02-15
HRP980258A2 (en) 1999-02-28
AU725530B2 (en) 2000-10-12
AR011729A1 (es) 2000-08-30
CN1263528A (zh) 2000-08-16
ES2190081T3 (es) 2003-07-16
BR9811465A (pt) 2000-09-12
CZ400699A3 (cs) 2000-02-16
CZ289484B6 (cs) 2002-01-16
TW396155B (en) 2000-07-01
UY24997A1 (es) 2000-10-31
ID22911A (id) 1999-12-16
RU2175323C2 (ru) 2001-10-27
DE69811223T2 (de) 2003-11-27
SK154299A3 (en) 2000-05-16
HUP0002763A3 (en) 2002-05-28
DE69811223D1 (de) 2003-03-13
IS5235A (is) 1999-10-29
EP0984960A1 (fr) 2000-03-15
SI0984960T1 (en) 2003-06-30
EP0984960B1 (fr) 2003-02-05
DZ2486A1 (fr) 2003-02-01
NZ500637A (en) 2000-11-24
WO1998051686A1 (fr) 1998-11-19
PL336772A1 (en) 2000-07-17
DK0984960T3 (da) 2003-05-26
ATE232207T1 (de) 2003-02-15
HRP980258B1 (en) 2002-08-31
ZA983997B (en) 1999-11-12
JP2001524980A (ja) 2001-12-04
AU7659998A (en) 1998-12-08
CA2289573A1 (fr) 1998-11-19
CO4940485A1 (es) 2000-07-24
NO995513L (no) 2000-01-12

Similar Documents

Publication Publication Date Title
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
BR9702553A (pt) Composição cosmética e utilização
EE200000232A (et) Farmatseutiline kompositsioon ja selle kasutamine
FI990466A0 (fi) Aktivaattorit ja laite
EE9700209A (et) Dihüdropürimidiinid ja nende kasutamine
EE200200251A (et) Uued N-asabitsükloamiidi derivaadid ja nende kasutamine
NO20000125L (no) Tiadiazolyl- og oksadiazolylfenyloksazolidinon- antibakterielle midler
TR199501305A2 (tr) Heterosiklik bilesikler ve bunlarin hazirlanmasi ve kullanimi
IS5430A (is) Ný samsetning
ID24196A (id) Komposisi dan penggunaan
BR9502407A (pt) Composição lubrificante e concetrado
EE9900524A (et) N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena
FI964031A (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
BR9509688A (pt) Composto e composição farmacêutica
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
FI971317A0 (fi) Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö
FI982682A0 (fi) Uusi komposiitti ja sen käyttö
FI19992526A (fi) Sahakokoonpano
FI972010A0 (fi) Arrangemang i en borrningsanordning
BR9505130A (pt) Composto e composiçao farmacêutica
DE59812220D1 (de) Halte- und trageband
SE9900878D0 (sv) New composition and use thereof
SE9703737D0 (sv) Pharmaceutical composition and use
SE9803771D0 (sv) Pharmaceutical composition and use
BA98291A (bs) Epoksi-azetidinoni priprava i upotreba